Clinical Trial Update: Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether neoadjuvant radiotherapy improves recurrence-free survival in pancreatic head cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: CHIR-Net | Conditions: Pancreatic Adenocarcinoma | Phase 3 | Status: TERMINATED